Cargando…
Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer
BACKGROUND: Viral-mediated oncolysis is a novel cancer therapeutic approach with the potential to be more effective and less toxic than current therapies due to the agents selective growth and amplification in tumor cells. To date, these agents have been highly safe in patients but have generally fa...
Autores principales: | Kuhn, Irene, Harden, Paul, Bauzon, Maxine, Chartier, Cecile, Nye, Julie, Thorne, Steve, Reid, Tony, Ni, Shaoheng, Lieber, Andre, Fisher, Kerry, Seymour, Len, Rubanyi, Gabor M., Harkins, Richard N., Hermiston, Terry W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423470/ https://www.ncbi.nlm.nih.gov/pubmed/18560559 http://dx.doi.org/10.1371/journal.pone.0002409 |
Ejemplares similares
-
OvAd1, a Novel, Potent, and Selective Chimeric Oncolytic Virus Developed for Ovarian Cancer by 3D-Directed Evolution
por: Kuhn, Irene, et al.
Publicado: (2016) -
Oncolytic Viruses: The Power of Directed Evolution
por: Bauzon, Maxine, et al.
Publicado: (2012) -
Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus
por: Illingworth, Sam, et al.
Publicado: (2017) -
Armed Therapeutic Viruses – A Disruptive Therapy on the Horizon of Cancer Immunotherapy
por: Bauzon, Maxine, et al.
Publicado: (2014) -
Oncolytic viruses: finally delivering
por: Seymour, Leonard W, et al.
Publicado: (2016)